Site icon AIT365

Innovaccer Acquires Story Health to Advance AI in Specialty Care

Innovaccer

Innovaccer, a leading healthcare AI company, announced the acquisition of Story Health, an AI-driven, tech-enabled platform dedicated to transforming specialty care from episodic interactions into continuous, digital-first care models. This move reinforces Innovaccer’s strategic expansion following acquisitions of Humbi AI, Cured, and Pharmacy Quality Solutions, extending its Healthcare Intelligence Cloud into agentic care augmentation.

Over the years, Innovaccer has established a comprehensive healthcare operating system that spans data unification, patient engagement, pharmacy quality, and actuarial intelligence. The addition of Story Health strengthens this foundation by bringing advanced AI-enabled tools designed to empower specialty care teams.

Founded in 2020 by Google veterans Tom Stanis and Nikhil Roy, along with cardiologist Ashul Govil, MD, MBA, Story Health developed a vertically integrated cardiovascular care platform that shifts treatment from periodic clinic visits to continuous, digitally enabled management. Leveraging AI-powered clinical pathways, sophisticated medication workflows, and human-led coaching, the platform has delivered industry-leading outcomes across heart failure, hypertension, and atrial fibrillation (AFib). Health systems using Story Health report a 6.9% 30-day heart failure all-cause readmission rate significantly lower than the national average of 18.1% along with over 60% reductions in hospitalizations and measurable improvements in medication adherence and daily engagement.

By integrating Story Health’s capabilities, Innovaccer will advance agentic care augmentation, enabling AI agents to support specialty care teams with non-clinical tasks and continuous patient engagement. Human health coaches, working alongside AI systems, can communicate with patients about symptoms and medication adherence, monitor remote patient data, and trigger timely interventions. Embedding these workflows into EHR systems allows health systems to scale specialty care, reduce readmissions, and improve adherence without increasing clinician workload.

Also Read: LabConnect & OmniScience launch agentic AI for trial data

“Healthcare doesn’t change through dashboards alone,” said Abhinav Shashank, cofounder and CEO of Innovaccer. “It changes when data and AI power completely new clinical models. Story Health has proven that in specialty care; and we’re excited to bring this technology and clinical expertise to our health system customers nationwide.”

Tom Stanis, cofounder and CEO of Story Health, added, “When we built Story Health, we believed specialty care needed more than software, it needed an operating model. Most platforms stop at insights. Story Health goes all the way to action. Joining forces allows us to scale nationally and turn continuous, AI-assisted specialty care into the new normal.”

The acquisition enhances Innovaccer’s Healthcare Intelligence Cloud, accelerating scalable clinical transformation for providers and health plans across the U.S.

“Story Health has helped us reimagine how we deliver cardiac care at ChristianaCare. By extending care beyond the walls of our clinics and into the daily lives of our patients, we’ve seen improvements in medication adherence, fewer hospitalizations, and stronger engagement between visits,” said Kirk Garratt, MD, Medical Director of the Center for Heart and Vascular Health and Chair of Cardiology at ChristianaCare. “The integration with Innovaccer will allow us to scale this model further, empowering our teams to provide continuous, personalized care without adding to clinician burden. This is a critical step forward in making advanced, AI-enabled specialty care accessible to more patients in our community.”

Story Health customers will continue to receive uninterrupted services while gaining access to Innovaccer’s expanded AI-powered solutions. Looking ahead, Story Health plans to broaden its impact by addressing chronic conditions beyond cardiology, including diabetes and COPD. The combined platform will deliver fully integrated clinical pathways across both primary and specialty care, enabling health systems to achieve new levels of efficiency, scalability, and clinical precision.

Exit mobile version